tients with Dent's disease. Endocytosis and processing of LMW proteins involve the multiligand tandem receptors, megalin and cubilin, that are abundantly expressed at the brush border of PT cells. Characterization of the endocytic defect in ClC-5 KO mice revealed that ligands of both megalin and cubilin were affected. The total kidney content of megalin and especially cubilin at the protein level was decreased but, more importantly, using analytical subcellular fractionation and quantitative immunogold labelling we demonstrated a selective disappearance of megalin and cubilin at the brush border of PT cells. These observations allowed us to conclude that defective protein endocytosis linked to ClC-5 inactivation is due at least in part to a major and selective loss of megalin and cubilin at the brush border, refl ecting a traffi cking defect in renal PT cells. These results improve our understanding of Dent's disease, taken as a paradigm for renal Fanconi syndrome and nephrolithiasis, and demonstrate multiple roles for ClC-5 in the kidney. These studies also provided insights into important functions such as apical endocytosis, handling of proteins by renal tubular cells, calcium metabolism, and urinary acidifi cation.
plicated by nephrocalcinosis and renal failure. Nephrolithiasis occurs as an inherited disorder in about half the patients and is most commonly associated with hypercalciuria. The biochemical basis for hereditary nephrolithiasis and hypercalciuria is unknown, which has hampered therapeutic developments [1] .
Recent genetic studies have provided important clues to the understanding of nephrolithiasis. Three disorders of hypercalciuric nephrolithiasis (Dent's disease and its variants X-linked recessive nephrolithiasis and X-linked recessive hypophosphatemic rickets) have been mapped to Xp11.22 [2] . These disorders are characterized by a dysfunction of the renal proximal tubule (PT; renal Fanconi syndrome), with low-molecular weight (LMW) proteinuria, hypercalciuria, nephrocalcinosis, nephrolithiasis and renal failure [3] . A search for renally expressed genes from this region identifi ed inactivating mutations of CLCN5 , a member of the CLC family of voltage-gated chloride channels, in Dent's disease and its variants [4] . Despite these genetic advances, the mechanisms whereby the loss of a chloride channel leads to hypercalciuria and renal tubular defects remain unknown.
This review describes a series of molecular investigations that allowed us to investigate the pathophysiology of Dent's disease taken as a paradigm of renal tubular disease and nephrolithiasis. These studies provided new insights into the role of chloride channels in apical endocytosis and renal tubular handling of proteins, calcium and protons.
Intrarenal and Subcellular Distribution of ClC-5 Suggests a Pathophysiological Basis for Dent's Disease
CLCN5 belongs to the CLC family of voltage-gated chloride channel genes, of which nine different members have been identifi ed in mammals. These chloride channels are important for the control of membrane excitability, transepithelial transport, and possibly regulation of cell volume [5] . CLCN5 is predominantly expressed in the kidney. It encodes ClC-5, a 746-amino acid protein that induces strong outwardly rectifying chloride currents in heterologous expression systems. These currents are markedly reduced or abolished by mutations of Dent's disease [3] [4] [5] .
In order to understand how the loss of the chloride channel ClC-5 leads to multiple renal tubular defects, we analyzed the segmental and subcellular expression of ClC-5 in the kidney [6] . Immunoblotting studies identifi ed the ~80-kDa ClC-5 in human kidney cortex and medulla. Immunohistochemistry revealed ClC-5 expression in epithelial cells lining the PT, the thick ascending limb (TAL) of Henle's loop, and the intercalated cells (ICs) of the collecting ducts. Analytical subcellular fractionation of the human kidney suggested that ClC-5 colocalizes with the vacuolar H + -ATPase and is associated with markers of early endosomes (Rab 5a). Confocal microscopy studies using opossum kidney (OK) cells, a model for PT cells, confi rmed that ClC-5 colocalized with albumincontaining endocytic vesicles that form part of the receptor-mediated endocytic pathway [6] .
Taken together, these studies indicated that the expression of ClC-5 in multiple nephron segments could explain the complex phenotype of Dent's disease. A loss of ClC-5 function in the TAL, which is a major site of regulated calcium reabsorption, may result in hypercalciuria. Since the reabsorption of LMW proteins is restricted to the PT and involves endocytosis with subsequent transport to the acidic vacuolar-lysosomal system, dysfunction of ClC-5 in PT endosomes may impair endosomal acidifi cation and lead to ineffi cient reabsorption of LMW proteins and dysfunction of PT cells.
Characterization of a ClC-5 Knockout Mouse Model for Dent's Disease
Dent's disease is thus characterized by PT defects that include LMW proteinuria, and usually aminoaciduria and glycosuria, together with hypercalciuria and nephrocalcinosis. In order to better understand the roles of ClC-5 and the pathophysiology of Dent's disease, we characterized a ClC-5 knockout (KO) mouse obtained by homologous recombination targeting exon VI of Clcn5 [7] . The KO mice were viable at birth and showed normal growth and survival. Northern and Western blot analyses confi rmed the absence of ClC-5 in the kidneys of KO mice. Mice lacking ClC-5 developed renal tubular defects, which included LMW proteinuria, aminoaciduria, glycosuria, phosphaturia and polyuria. They also developed hypercalciuria and nephrocalcinosis, while progressive renal failure was observed with aging. Further investigations indicated that the hypercalciuria in the ClC-5 KO mice is of bone and renal origin, and is not caused by increased intestinal calcium absorption -despite elevated levels of 1 ␣ ,25-dihydroxyvitamin D3 [8] .
LMW proteins ( ! 70 kDa) are normally fi ltered at the glomerulus and avidly recaptured by receptor-mediated endocytosis in PT cells. ClC-5 has been localized to early endosomes belonging to this pathway [6] . In order to study this process more closely, mice were injected with peroxidase, a classical endocytic tracer that is fi ltered by the glomerulus and endocytosed by PT cells. Cytochemistry and electron microscopy showed a severe impairment of protein endocytosis by PT cells in ClC-5 KO mice, so that peroxidase bound to the brush border was poorly transferred into early endocytic vesicles [7] . These data, which were confi rmed in another mouse model [9] , demonstrated that impairment of receptor-mediated endocytosis in PT cells of Clcn5 -defi cient mice provides a basis for the defective uptake and increased urinary excretion of LMW proteins.
Loss of ClC-5 Impairs Endocytosis by Defective Traffi cking in Kidney Proximal Tubules
The endocytosis and processing of LMW proteins involve the multiligand tandem receptors, megalin and cubilin, that are abundantly expressed at the brush border of PT cells [10] . Megalin, the largest member of the LDL receptor family, interacts with cubilin and both receptors are internalized together. Diseases of PT cells, collectively called renal Fanconi syndromes, are all characterized by LMW proteinuria. This is reproduced in megalin KO mice and cubilin-defective dogs [10] .
Since progression along the endocytic apparatus depends on endosomal acidifi cation, the defective endocytosis observed in Dent's disease [4] and ClC-5 KO mice [7, 9] has been attributed to impaired endosomal acidification secondary to loss of chloride permeability. However, drugs abrogating vacuolar acidifi cation do not affect the rate of endocytic uptake, but inhibit recycling or arrest transfer to lysosomes [11] . We therefore looked for a more specifi c alteration along the endocytic pathway in Dent's disease, i.e. a lack of the essential components, megalin and cubilin, at the brush border. To this aim, we extensively characterized the endocytic defect in ClC-5 KO mice and found that ligands of both megalin and cubilin were affected. Next, we showed a decrease in total kidney content of megalin and cubilin at the protein level but not at the mRNA level. Finally, using analytical subcellular fractionation and quantitative immunogold labelling, we demonstrated a selective disappearance of megalin and cubilin at the brush border of PT cells. These observations allowed us to conclude that defective protein endocytosis linked to ClC-5 inactivation is due to a major and selective loss of megalin and cubilin at the brush border, refl ecting a traffi cking defect in renal PT cells [11] . [6] . Studies of KO mice [7] have established the role of ClC-5 in PT endocytosis, but the consequences of ClC-5 mutations on the human kidney remained unknown.
We have established a multicentric database of renal biopsies from patients with Dent's disease and documented inactivating ClC-5 mutations [12] . Light microscopy revealed a normal renal architecture or glomerulosclerosis, tubular dedifferentiation, and mild interstitial fi brosis. Renal calcifi cations were identifi ed at all stages. Despite the generalized PT dysfunction, electron microscopy did not reveal any ultrastructural abnormalities in PT cells, and the endocytic apparatus was normal. However, immunohistochemistry studies demonstrated a consistent inversion of H + -ATPase polarity in PT cells to a basolateral distribution contrasting with its apical location in the normal kidney. This inversion of polarity was specifi c and did not affect distribution of aminopeptidase, megalin or Na -ATPase that would be essential for the proper targeting or stability of the latter. These data are important in the investigation of molecular interactions involving ClC-5 and help us to understand some aspects of Dent's disease, namely the defi cit in urinary acidifi cation observed in some patients [3] .
Comparative Ontogeny and Segmental Distribution of ClC-5
The clinical manifestations of Dent's disease often occur during childhood, and LMW proteinuria is a consistent feature of the disease. In particular, the early onset of some cases, in which tubular proteinuria was discovered in the fi rst month of life [13] , suggests that segmental expression of ClC-5 in PT must be acquired before birth. We have recently investigated the ontogeny of ClC-5, and its processing and segmental distribution during nephrogenesis [14] . These studies showed that ClC-5 undergoes a rapid induction at an early stage of mouse nephrogenesis, followed by a progressive maturation during late nephrogenesis. Studies with the enzyme PGNase p72 F confi rmed the early N-linked glycosylation of ClC-5, and the progressive maturation of the core protein during nephrogenesis. The distribution of ClC-5 in PT and ␣ -type IC, and its colocalization with H + -ATPase at these locations, are already achieved at embryonic day (E) 15.5. In human nephrogenesis, ClC-5 is detected early during the second trimester, with a distribution that includes developing PT cells and, later, IC. These results complete early observations that the apical expression of brush border components and the distribution of megalin to the apical clathrin-coated membrane domains and endosomes coincide with the onset of glomerular fi ltration in rats [15] . The coexpression of ClC-5 and H + -ATPase in PT cells immediately after initiation of glomerular fi ltration could thus indicate the progressive maturation of renal tubular function and explain the decrease in the concentration of LMW proteins in the amniotic fl uid during gestation [16] , as well as the early phenotypic variants of Dent's disease [13] .
In addition to PT cells, ClC-5 and H + -ATPase are codetected from E15.5 in mouse in the apical area of ␣ -type IC [14] . In human nephrogenesis, isolated cells positive for carbonic anhydrase type II (CAII) are identifi ed within ureteric buds and medullary collecting ducts (CDs) at 15 gestation weeks (GW), and rare, isolated cells positive for H + -ATPase are identifi ed at 19 GW. In contrast, ClC-5 could not be identifi ed in IC before 24 GW. The colocalization of ClC-5 with CAII and/or H + -ATPase in IC was only observed postnatally, confi rming data obtained in mature kidney [6] . These results suggest species differences in the maturation of IC [17] and support the hypothesis that, in humans, the differentiation of IC occurs later than that of the principal cells of the CD [18] .
Recent Developments and Perspectives
Recent developments in the molecular genetics and pathophysiology of Dent's disease should be pointed out. Crucially important information is the demonstration that Dent's disease is genetically heterogeneous. In a careful analysis, Hoopes et al. [19] were unable to fi nd mutations in the coding sequence and promoter regions of CLCN5 in 13 of 32 unrelated patients meeting the clinical criteria for the disease. Furthermore, they excluded linkage to the CLCN5 region in a three-generation family [19] . These data suggest that mutations in genes different from CLCN5 can be involved in Dent's disease. These genes presumably code for proteins that interact, directly or indirectly, with ClC-5. For instance, an interaction between the C-terminus of ClC-5 and cofi lin, a protein involved in the depolymerization of actin in the immediate vicinity of endosomes, has been documented in cultured cells of PT origin [20] . This could be crucial for mediating uptake of LMW proteins by PT cells.
In addition to genetic heterogeneity, mutation analysis has provided valuable information relating to the structure of ClC-5. The X-ray crystal structures of two bacterial CLC proteins at 3.0-Å resolution have recently been established [21] , confi rming the prediction that the CLC channels are homodimers with a double-barreled confi guration. Each subunit has its own pore and 17 ␣ -helices inserted into the plasma membrane, with an anti-parallel orientation that brings together residues responsible for anion selectivity [21] . Based on these data, a model for human ClC-5 has been established, allowing analysis of the role of 15 non-truncating mutations (14 missense and one in-frame deletion) of CLCN5 [22] . This analysis revealed that none of these mutations involves the selectivity fi lter, but that most of them (12/15) are clustered at the interface of the two subunits of the homodimeric channel [22] . The functional evaluation of other naturally occurring mutants is necessary in order to defi ne the role of conserved domains for ClC-5 function and/or traffi cking: a case in point is a C-terminus internalization motif, resembling the PY motif that is essential for the internalization and degradation of the epithelial sodium channel, ENaC [23] .
In addition to PT and IC cells, ClC-5 is expressed in the TAL of Henle's loop [6] , but its role in this segment remains unclear. However, recent data obtained in a cultured TAL murine cell line, as well as in mice exposed to water deprivation, suggest that exposure to hypertonicity upregulates the expression of ClC-5 at the mRNA and protein levels. Thus, the regulation of ClC-5 expression may be crucial for the adaptation to a hypertonic environment and the preservation of correct endocytic activity/ targeting in TAL cells [24] .
A central hypothesis is that ClC-5 provides the chloride conductance necessary for endosomal acidifi cation by the electrogenic vacuolar H + -ATPase [7, 9, 25] . Based on decreased ATP-dependent fl uorescence quenching of lowdensity vesicles isolated from ClC-5 KO mice loaded in vitro by acridine orange, preliminary data from Gunther et al. [26] support this view. However, these vesicles were not characterized as early endosomes (the well-documented traffi cking defect in the PT cells of ClC-5 KO mice may impair their purifi cation and yield contamination by nonendocytic acidifi ed organelles), and the residual quenching in these KO vesicles still showed chloride dependence Chloride Channels and Endocytosis Nephron Physiol 2005;99:p69-p73 p73 [26] . In other words, a crucial role of ClC-5 in endosomal acidifi cation remains to be proven.
Conclusions
The studies outlined here have provided critical information to understand the pathophysiology of Dent's disease, taken as a paradigm for renal Fanconi syndrome and nephrolithiasis. The characterization of the cellular and subcellular distribution of ClC-5 and detailed investigations in the ClC-5 KO mouse have demonstrated multiple roles for this chloride channel in the kidney. These studies also provided novel insights into essential functions such as apical endocytosis, handling of proteins by renal tubular cells, calcium metabolism, and urinary acidifi cation. This information and the validation of a mouse model that harbors essential traits such as hypercalciuria and nephrocalcinosis should now prove useful in the development of therapeutic strategies relevant for Dent's disease, renal Fanconi syndromes and kidney stones.
